AnalystsInsight

Mark Lear (Scotiabank): Analyst Track Record and Price‑Target Accuracy

How often Mark Lear’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 2,340 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Mark Lear ranks #792 of 1,121 analysts in Exent’s scoring (4.7★).
  • 37.9% of price targets were reached over 7 years, versus 53.6% for the average analyst.
  • Median time to reach a target: 106 days; 64.4% of calls were up 12 months later.
  • Most‑covered stocks: DVN, OXY, EOG, FANG.
  • Free on Exent: Mark Lear’s full record, with ratings 3 days after publication.

Mark Lear’s track record at a glance

Mark Lear of Scotiabank ranks #792 of the 1,121 analysts Exent scores, with a 4.7★ rating and a focus on energy. Over a 7‑year lookback, 37.9% of Mark’s price targets were reached, 15.7 points below the 53.6% average across all analysts.

MetricMark LearAll analysts
Price‑target hit rate37.9%53.6%
Median days to hit target106 days91 days
Calls up after 12 months64.4%64.6%
Median 12‑month return of calls+13.6%+13.4%
Hit rate, last 2 years49.7%—
Average worst drop after a call−16.8%—
Ratings in the sample2,340—
Stocks covered30—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetMark Lear
Under 30 days20.0%
30–90 days24.0%
90–180 days20.3%
Over 180 days35.7%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Mark Lear covers most

StockRatings in the sample
DVN31
OXY25
EOG23
FANG23
APA23
PR21
CRGY21
EXE21

In the past year Mark’s ratings were 41% Buy, 53% Hold and 5% Sell.

Mark Lear’s latest ratings

DateStockActionRatingPrice target
Oct 20, 2026
Oct 15, 2026TRGPReiterated: BuyBuy$319.00
Oct 15, 2026EOGInitiated: HoldHold$144.00
Oct 15, 2026MURInitiated: HoldHold$41.00
Oct 15, 2026FANGInitiated: BuyBuy$250.00
Oct 15, 2026APAInitiated: HoldHold$44.00
Oct 15, 2026PAAReiterated: BuyBuy$28.00
Oct 15, 2026PRInitiated: BuyBuy$29.00
Oct 15, 2026CHRDInitiated: BuyBuy$192.00
Oct 15, 2026TRGPMaintained: BuyBuy$319.00
Oct 15, 2026OXYInitiated: HoldHold$63.00
Oct 15, 2026DVNInitiated: BuyBuy$61.00
Oct 15, 2026PAAMaintained: BuyBuy$28.00
  • Oct 20, 2026
    Stock
    Action
    Rating
    Price target
  • Oct 15, 2026
    Stock
    TRGP
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $319.00
  • Oct 15, 2026
    Stock
    EOG
    Action
    Initiated: Hold
    Rating
    Hold
    Price target
    $144.00
  • Oct 15, 2026
    Stock
    MUR
    Action
    Initiated: Hold
    Rating
    Hold
    Price target
    $41.00
  • Oct 15, 2026
    Stock
    FANG
    Action
    Initiated: Buy
    Rating
    Buy
    Price target
    $250.00
  • Oct 15, 2026
    Stock
    APA
    Action
    Initiated: Hold
    Rating
    Hold
    Price target
    $44.00
  • Oct 15, 2026
    Stock
    PAA
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $28.00
  • Oct 15, 2026
    Stock
    PR
    Action
    Initiated: Buy
    Rating
    Buy
    Price target
    $29.00
  • Oct 15, 2026
    Stock
    CHRD
    Action
    Initiated: Buy
    Rating
    Buy
    Price target
    $192.00
  • Oct 15, 2026
    Stock
    TRGP
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $319.00
  • Oct 15, 2026
    Stock
    OXY
    Action
    Initiated: Hold
    Rating
    Hold
    Price target
    $63.00
  • Oct 15, 2026
    Stock
    DVN
    Action
    Initiated: Buy
    Rating
    Buy
    Price target
    $61.00
  • Oct 15, 2026
    Stock
    PAA
    Action
    Maintained: Buy
    Rating
    Buy
    Price target
    $28.00

Mark published 1 rating in the last 3 days, the latest on Oct 20, 2026. Mark’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Oct 20, 2026; ranking updated Oct 21, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Mark Lear’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Mark Lear ranks #792 of 1,121 with a 4.7★ rating. 37.9% of price targets were reached over a 7-year lookback (all analysts: 53.6%), and 64.4% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Mark Lear’s success rate is 60.8% by the ranking source and 37.9% by Exent’s price-target hit-rate backtest, with a median of 106 days to reach a target.

Mark Lear (Scotiabank) covers 30 stocks, mostly in energy. The most frequently rated are DVN, OXY, EOG, FANG, APA.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.